BofA analyst Peter Galbo lowered the firm’s price target on Colgate-Palmolive (CL) to $102 from $105 and keeps a Buy rating on the shares. Ahead of Q1 earnings, the firm updated estimates for organic sales and FY26 EPS to reflect several items, including a shift in launch timing on Optic White in North America impacting consumption and incorporating a more conservative gross margin view for the potential impact from rising oil costs, the analyst tells investors in a preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive: Maintaining Buy Rating on Defensive Strength and Premium Valuation Despite Near-Term Margin Headwinds
- Colgate-Palmolive Announces Planned Chief Legal Officer Succession
- Colgate-Palmolive price target lowered to $102 from $104 at RBC Capital
- Colgate-Palmolive price target lowered to $92 from $96 at Piper Sandler
- Colgate-Palmolive price target lowered to $92 from $100 at Wells Fargo